Viral Hemorrhagic Fever Latest Advances

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report.

Journal: Acta medica Indonesiana

Published: April 14, 2026

Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025.

Journal: The Pediatric infectious disease journal

Published: April 13, 2026

CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Analysis of the Spatial Distribution Characteristics of the Peak Density of Rodents and Mosquitoes in the Main Urban Area of Hefei in 2024.

Journal: Vector borne and zoonotic diseases (Larchmont, N.Y.)

Published: April 10, 2026

Correction: In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus.

Journal: Virology journal

Published: April 10, 2026

ISG15-USP18 signaling restrains viperin-dependent metabolic antiviral restriction.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Journal: The New England journal of medicine

Published: April 08, 2026

Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August-November 2024.

Journal: Emerging infectious diseases

Published: April 06, 2026

Recombinant expression of rift valley fever virus nucleocapsid protein and generation of rabbit polyclonal antibodies

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: April 03, 2026

Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.

Journal: Virulence

Published: April 03, 2026

Plasma proteomics identifies early markers of endothelial and inflammatory activation associated with dengue disease severity in children.

Journal: medRxiv : the preprint server for health sciences

Published: April 03, 2026

Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responses.

Journal: medRxiv : the preprint server for health sciences

Published: April 03, 2026

Viral Hemorrhagic Fever Latest Advances

Find the Latest Research About Viral Hemorrhagic Fever

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report.

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report.

Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025.

Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025.

CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.

CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.

Analysis of the Spatial Distribution Characteristics of the Peak Density of Rodents and Mosquitoes in the Main Urban Area of Hefei in 2024.

Analysis of the Spatial Distribution Characteristics of the Peak Density of Rodents and Mosquitoes in the Main Urban Area of Hefei in 2024.

Correction: In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus.

Correction: In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus.

ISG15-USP18 signaling restrains viperin-dependent metabolic antiviral restriction.

ISG15-USP18 signaling restrains viperin-dependent metabolic antiviral restriction.

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August-November 2024.

Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August-November 2024.

Recombinant expression of rift valley fever virus nucleocapsid protein and generation of rabbit polyclonal antibodies

Recombinant expression of rift valley fever virus nucleocapsid protein and generation of rabbit polyclonal antibodies

Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.

Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.

Plasma proteomics identifies early markers of endothelial and inflammatory activation associated with dengue disease severity in children.

Plasma proteomics identifies early markers of endothelial and inflammatory activation associated with dengue disease severity in children.

Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responses.

Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responses.